Tue, Sep 30, 2014, 3:45 PM EDT - U.S. Markets close in 15 mins.

Recent

% | $
Quotes you view appear here for quick access.

Bio-Reference Laboratories Inc. Message Board

SortNewest  |  Oldest  |  Highest Rated Expand all messages
  • Just reported in formal 8k filing by PURE:
    The owner of Subway, the largest food chain in the world, through Franchise Brands, LLC, just invested $4million in PURE Bioscience as a strategic investment. This strongly implies that some very large restaurant chains will soon start buying “SDC” in very large quantities. Do you think it might be the 45,000 restaurant Subway?

    Several other major QSR’s are likely to follow soon.

    PURE is very STRONG BUY because they have almost $8 million in cash, the biggest breakthrough in food safety in decades using biotechnology, and revenues that are about to explode.

    Sentiment: Strong Buy

  • Type “MicroCapReview” into your browser to learn why Millennium HealthCare (MHCC) stock price is about to explode and keep going for years. Click on “Read the latest issue and turn to page 22.

    Sentiment: Strong Buy

  • Reply to

    Sold AAPL to BUY BRLI (the reason is..)

    by lmcgl Sep 5, 2014 9:47 AM

    I recently went deep in this company. Its surely an acquisition target, and who can deny the solid growth.
    Shorted big time but I like that. GL

  • Bio-Reference Laboratories BRLI -
    One of the largest full service labs in the U.S., Bio-Reference offers an array of testing services that range from blood to genetic to urinalysis to pap smears. The small-cap ($880 million) has some very solid fundamentals, with just one dip in annual earnings per share over the past decade; $39 million in annual earnings vs. $16 million in debt; and a 17.3% return on equity over the past decade. These solid fundamentals help Bio-Reference score 92% according to my Warren Buffett based model. While Buffett and Berkshire might be limited to larger cap names, individual investors can take advantage of their small size by buying up values like Bio-Reference

  • Revenues driven by recent contracts for the most advanced life saving diagnostics will expand 150 times in the next 24 months. And that is just the beginning!

    Millennium Healthcare (MHCC) recently announced newly SIGNED contracts with ACO’s IPA’s and MSO’s to provide exclusive, state-of-the-art, non-invasive cardiovascular and cancer diagnostics to 1,300 locations that will escalate Millennium’s current revenues of $2 million per year to over $300 million per year.

    Cardiovascular and cancer diagnostics rolling out to physician’s offices this year.

    Revenues will begin rapid growth by year end.

    Market size for Millennium Diagnostics is 35,000 primary care offices. The first 1,300 recently contracted with Millennium and the rest are standing in line to sign up with Millennium because:

    § Millenniums program increases physician’s revenues dramatically
    § Millennium’s diagnostics are fully paid by Medicare and are free to patients
    § Millennium’s diagnostics appeal to patients because they are life-saving, fast, painless and highly accurate
    § Millennium’s diagnostics are exclusive from Millennium only
    § The physician pays no up front capital costs

    Millennium’s market cap is under $40 million today and shares are selling at under $1.00.

    What will this growth do to the price of MHCC shares?

    Millennium HealthCare is well positioned for explosive growth that is rarely seen.

    Sentiment: Strong Buy

BRLI
28.19-0.20(-0.70%)3:44 PMEDT

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.